Cephalon Tries To Nix Approval For Generic Fentora
Cephalon Inc. filed suit Tuesday in Washington in an effort to revoke federal approval of Watson Pharmaceuticals Inc.'s generic version of painkiller Fentora, after a judge invalidated two patents covering the...To view the full article, register now.
Already a subscriber? Click here to view full article